BPR277

LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
CP Wire
Mon, 08/27/18 - 09:54 am
LifeMax Laboratories
Novartis
BPR277
Netherton Syndrome
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
Mon, 08/27/18 - 09:12 am
LifeMax Laboratories
Novartis
BPR277
Netherton Syndrome